<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-46004-54249-001-LN3997</iati-identifier>
  <reporting-org ref="XM-DAC-46004" type="40">
   <narrative xml:lang="EN">Asian Development Bank</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">COVID-19: Imexpharm COVID-19 Generic Pharmaceutical Project</narrative>
  </title>
  <description>
   <narrative xml:lang="EN">The proceeds of the Asian Development Bank (ADB) loan and Imexpharm&apos;s internal cash accruals will be used to fund Imexpharm&apos;s working capital needs amid the global coronavirus disease  (COVID-19)  pandemic  and  the  resulting  economic  crisis.  The  project  is  an  indirect COVID-19 response to address the challenges that arose as a result of supply chain constraints during the COVID-19 pandemic. Pharmaceutical manufacturers such as Imexpharm have had to stockpile inputs amid the supply disruption of pharmaceutical inputs. ADB&apos;s funding will be partly utilized  for  the  retroactive  financing  of  capital  needs  since  the  beginning  of  the  COVID-19 pandemic. Imexpharm has so far managed the increased cash needs by negotiating extended payment  terms  with  its  suppliers  and  using  internal  cash  accruals  in  anticipation  of  ADB&apos;s financing. The proceeds will be used for (i) the purchase of ingredients for pharmaceutical drug manufacturing and (ii) other general working capital needs.</narrative>
  </description>
  <participating-org activity-id="XM-DAC-46004-54249-001-LN3997" ref="XM-DAC-46004" role="1" type="40">
   <narrative xml:lang="EN">Asian Development Bank</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-46004-54249-001-LN3997" ref="XM-DAC-46004" role="2" type="70">
   <narrative xml:lang="EN">Imexpharm Corporation</narrative>
  </participating-org>
  <other-identifier ref="46004" type="B1">
   <owner-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-05-06" type="1"></activity-date>
  <activity-date iso-date="2020-05-06" type="2"></activity-date>
  <activity-date iso-date="2026-02-03" type="3"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN">Junnosuke Kobayashi</narrative>
   </person-name>
   <email>jkobayashi@adb.org</email>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-country code="VN" percentage="100"></recipient-country>
  <location>
   <location-id code="1582562" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">Tinh Dong Thap</narrative>
   </name>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>10.58333 105.63333</pos>
   </point>
  </location>
  <sector code="12220" percentage="100" vocabulary="1"></sector>
  <country-budget-items vocabulary="1">
   <budget-item code="5.1.1" percentage="100" vocabulary="1"></budget-item>
  </country-budget-items>
  <policy-marker code="INCLUSIVE ECONOMIC GROWTH" vocabulary="99" vocabulary-uri="https://www.adb.org/sites/default/files/institutional-document/54249/files/project-classification-system-final-report.pdf">
   <narrative xml:lang="EN">Inclusive economic growth</narrative>
  </policy-marker>
  <policy-marker code="PARTNERSHIPS" vocabulary="99" vocabulary-uri="https://www.adb.org/sites/default/files/institutional-document/54249/files/project-classification-system-final-report.pdf">
   <narrative xml:lang="EN">Partnerships</narrative>
  </policy-marker>
  <policy-marker code="PRIVATE SECTOR DEVELOPMENT" vocabulary="99" vocabulary-uri="https://www.adb.org/sites/default/files/institutional-document/54249/files/project-classification-system-final-report.pdf">
   <narrative xml:lang="EN">Private sector development</narrative>
  </policy-marker>
  <policy-marker code="SOME GENDER ELEMENTS (SGE)" vocabulary="99" vocabulary-uri="https://www.adb.org/sites/default/files/institutional-document/54249/files/project-classification-system-final-report.pdf">
   <narrative xml:lang="EN">Some gender elements (SGE)</narrative>
  </policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="20"></default-flow-type>
  <default-finance-type code="421"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget>
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="USD" value-date="2020-06-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2020-07-01"></period-start>
   <period-end iso-date="2020-09-30"></period-end>
   <value currency="USD" value-date="2020-09-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2020-10-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2020-12-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2021-03-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-06-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2021-09-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-12-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2022-03-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2022-06-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2022-09-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-12-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2023-03-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2023-06-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2023-09-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2023-12-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2024-01-01"></period-start>
   <period-end iso-date="2024-03-31"></period-end>
   <value currency="USD" value-date="2024-03-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2024-04-01"></period-start>
   <period-end iso-date="2024-06-30"></period-end>
   <value currency="USD" value-date="2024-06-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2024-07-01"></period-start>
   <period-end iso-date="2024-09-30"></period-end>
   <value currency="USD" value-date="2024-09-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2024-10-01"></period-start>
   <period-end iso-date="2024-12-31"></period-end>
   <value currency="USD" value-date="2024-12-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2025-01-01"></period-start>
   <period-end iso-date="2025-03-31"></period-end>
   <value currency="USD" value-date="2025-03-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2025-04-01"></period-start>
   <period-end iso-date="2025-06-30"></period-end>
   <value currency="USD" value-date="2025-06-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2025-07-01"></period-start>
   <period-end iso-date="2025-09-30"></period-end>
   <value currency="USD" value-date="2025-09-30">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2025-10-01"></period-start>
   <period-end iso-date="2025-12-31"></period-end>
   <value currency="USD" value-date="2025-12-31">333333.33</value>
  </budget>
  <budget>
   <period-start iso-date="2026-01-01"></period-start>
   <period-end iso-date="2026-03-31"></period-end>
   <value currency="USD" value-date="2026-03-31">333333.33</value>
  </budget>
  <capital-spend percentage="100"></capital-spend>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-05-06"></transaction-date>
   <value currency="USD" value-date="2020-05-06">8000000</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="USD" value-date="2020-05-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-30"></transaction-date>
   <value currency="USD" value-date="2020-06-30">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-31"></transaction-date>
   <value currency="USD" value-date="2020-07-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-31"></transaction-date>
   <value currency="USD" value-date="2020-08-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2020-09-30">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-31"></transaction-date>
   <value currency="USD" value-date="2020-10-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-30"></transaction-date>
   <value currency="USD" value-date="2020-11-30">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-31"></transaction-date>
   <value currency="USD" value-date="2021-01-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="5"></transaction-type>
   <transaction-date iso-date="2021-01-31"></transaction-date>
   <value currency="USD" value-date="2021-01-31">10000</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-28"></transaction-date>
   <value currency="USD" value-date="2021-02-28">4000000</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="5"></transaction-type>
   <transaction-date iso-date="2021-02-28"></transaction-date>
   <value currency="USD" value-date="2021-02-28">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-31"></transaction-date>
   <value currency="USD" value-date="2021-03-31">4000000</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="5"></transaction-type>
   <transaction-date iso-date="2021-03-31"></transaction-date>
   <value currency="USD" value-date="2021-03-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="5"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-31"></transaction-date>
   <value currency="USD" value-date="2021-05-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="5"></transaction-type>
   <transaction-date iso-date="2021-05-31"></transaction-date>
   <value currency="USD" value-date="2021-05-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="5"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-31"></transaction-date>
   <value currency="USD" value-date="2021-07-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="5"></transaction-type>
   <transaction-date iso-date="2021-07-31"></transaction-date>
   <value currency="USD" value-date="2021-07-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-31"></transaction-date>
   <value currency="USD" value-date="2021-08-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="5"></transaction-type>
   <transaction-date iso-date="2021-08-31"></transaction-date>
   <value currency="USD" value-date="2021-08-31">78692.95</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="5"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-31"></transaction-date>
   <value currency="USD" value-date="2021-10-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="5"></transaction-type>
   <transaction-date iso-date="2021-10-31"></transaction-date>
   <value currency="USD" value-date="2021-10-31">0</value>
   <provider-org>
    <narrative xml:lang="EN">Asian Development Bank</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Imexpharm Corporation</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.adb.org/sites/default/files/project-documents/54249/54249-001-rrp-en.pdf">
   <title>
    <narrative xml:lang="EN">Faster Approach to Small Nonsovereign Transactions (FAST) Report</narrative>
   </title>
   <category code="A01"></category>
   <category code="A02"></category>
   <category code="A03"></category>
   <category code="A05"></category>
   <category code="A08"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-10-31"></document-date>
  </document-link>
  <conditions attached="0">
   <condition type="2">
    <narrative xml:lang="EN">Type 2</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Type 3</narrative>
   </condition>
  </conditions>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Design and Monitoring Framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Capacity of the health system during a health emergency and availability of essential medicines ensured</narrative>
   </description>
   <document-link format="APPLICATION/PDF" url="https://www.adb.org/sites/default/files/project-documents/54249/54249-001-rrp-en.pdf">
    <title>
     <narrative xml:lang="EN">Faster Approach to Small Nonsovereign Transactions (FAST) Report</narrative>
    </title>
    <category code="A08"></category>
    <language code="EN"></language>
    <document-date iso-date="2021-10-31"></document-date>
   </document-link>
   <indicator aggregation-status="0" ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Production of Cefotaxime 1 g, Levofloxacin 500 mg, Ceftazidim 1 g, Cefoperazon 1 g, Azithromycin 500 mg, and Paracetamol 500 mg increased, for an annual total of 71.2 million units (2019 baseline: 65.1 million units)</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">Capacity of the health system during a health emergency and availability of essential medicines ensured</narrative>
    </description>
    <baseline value="65100000" year="2019"></baseline>
   </indicator>
   <indicator aggregation-status="0" ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Production of oral pharmaceutical drugs at all Imexpharm manufacturing facilities sustained at the same range as before with an annual total of at least 922.6 million units in terms of sachets or pills (2019 baseline: 966.7 million units)</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">Capacity of the health system during a health emergency and availability of essential medicines ensured</narrative>
    </description>
    <baseline value="966700000" year="2019"></baseline>
   </indicator>
   <indicator aggregation-status="0" ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Manufacturing of injectable pharmaceutical drugs at all Imexpharm manufacturing facilities increased, with annual production of at least 15.5 million vials (2019 baseline: 9.8 million vials)</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">Capacity of the health system during a health emergency and availability of essential medicines ensured</narrative>
    </description>
    <baseline value="9800000" year="2019"></baseline>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
